Arcellx, Inc. Common Stock
Symbol: ACLX (NASDAQ)
84.76
▲ (0.81%) 0.685
Company Description:
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Key Stats
- Today's Open: $84.27
- Today's High: $86.06
- Today's Low: $84.02
- Today's Volume: 238.41K
- Yesterday Close: $84.07
- Yesterday High: $85.655
- Yesterday Low: $82.735
- Yesterday Volume: 429.42K
- Last Min Volume: 321
- Last Min High: $84.755
- Last Min Low: $84.755
- Last Min VWAP: $84.755
Company Profile
- Name: Arcellx, Inc. Common Stock
- Website: https://www.arcellx.com
- Listed Date: 2022-02-04
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001786205
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $4.70B
- Round Lot: 100
- Outstanding Shares: 55.46M
- Asset Type: CS
RECENT FILINGS FOR ACLX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-15 | 4 | View |
| 2025-10-15 | 144 | View |
| 2025-10-06 | 4 | View |
| 2025-10-03 | 144 | View |
| 2025-09-30 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-26 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-18 | 144 | View |
| 2025-09-08 | SCHEDULE 13G | View |
| 2025-08-29 | 4 | View |
| 2025-08-14 | SCHEDULE 13D/A | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-06-11 | 4 | View |
| 2025-06-10 | 144 | View |
| 2025-05-30 | 4 | View |
| 2025-05-30 | 4 | View |
Latest News on ACLX